The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: A Markov model with primary data

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Rosen, Sydney ^a,b,c   Long, Lawrence ^b,c   Sanne, Ian ^b,c   Stevens, Wendy S ^b,d   Fox, Matthew P ^a,b,c,e  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^e BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RITONAVIR; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COHORT ANALYSIS; COST; DRUG RESISTANCE; DRUG SUBSTITUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MARKOV MODEL; MATHEMATICAL MODEL; PRIORITY JOURNAL; SOUTH AFRICA; TREATMENT FAILURE; VIRUS RESISTANCE; COST OF ILLNESS; ECONOMICS; HUMAN IMMUNODEFICIENCY VIRUS; PHYSIOLOGY; PROBABILITY; VIROLOGY; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; COST OF ILLNESS; HIV; HIV INFECTIONS; HUMANS; MARKOV CHAINS; SOUTH AFRICA; VIRAL LOAD;

EID: 79959509872     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-24     Document Type: Article

References (6)

1. Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa. VC Marconi H Sunpath Z Lu M Gordon K Koranteng-Apeagyei J Hampton S Carpenter J Giddy D Ross H Holst E Losina BD Walker DR Kuritzkes South Africa Resistance Cohort Study Team, Clin Infect Dis 2008 46 1589 1597 10.1086/587109 18419495 (Pubitemid 351706742)
2. Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa. CL Wallis JW Mellors WD Venter I Sanne W Stevens, J Acquir Immune Defic Syndr 2010 53 480 484 10.1097/QAI. 0b013e3181bc478b 19801944
3. Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. Z El Khatib AM Ekstrom J Ledwaba L Mohapi F Laher A Karstaedt S Charalambous M Petzold D Katzenstein L Morris, AIDS 2010 24 1679 1687 10.1097/QAD.0b013e32833a097b 20453629
4. South Africa Department of Health, National Antiretroviral Treatment Guidelines Pretoria, National Department of Health 2004
5. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. L Long M Fox I Sanne S Rosen, AIDS 2010 24 915 919 10.1097/QAD. 0b013e3283360976 20042849
6. Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. MP Fox A Brennan M Maskew P MacPhail I Sanne, Trop Med Int Health 2010 15 405 413 20180931